Ethical Considerations in the Commercialization of Genetically Modified Organisms: Balancing Innovation and Public Trust

Abstract

The biotechnology encompasses all aspects of human existence, it has enormous commercial potential. Using a variety of methods to transmit specially designed gene assemblies is the most effective biotechnological strategy. Nevertheless, this intentional alteration and the products that derive from it have become a source of conflict worldwide. Despite their advantages, genetically modified organisms (GMOs) have long been viewed as a danger to human health and the environment. Therefore, various nations' biosafety standards have deemed it important to verify the viability of GMOs in controlled and confined environments for any possible threats they may cause. This essay explains the several facets of risk, including its evaluation and management, which are crucial when making decisions on the safe use of genetically modified organisms. Regulation implementation requires effective efforts. There is also discussion of the significance of risk assessment, management, and a precautionary approach in environmental accords and activism.